In 46 transgender people on testosterone with mild androgenetic alopecia, sublingual minoxidil increased midfrontal hair count by 15.7 hairs/cm2 vs placebo at 24 weeks (P=.03) but not vertex count; no serious adverse events.
RCTn = 46
Tang et al. Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial